ScholarLens Back to search
2000•Zhongliu fangzhi yanjiuRequires access

CIinical Study of HELF Combined Chemotherapy for PatientsWith Advanced Gastric Carcinoma

HE Ze

Open publisher page 0 citations

Abstract

Objective To study the effect of patients with advanced gstric carcinoma was systemic combined chemotherapy with ELF reginen,consisting of 10 hrdroxycmptothecine(HCPT),etoposide(Vp 16),Leucovorin(LV)and 5 fluorouracil(5 Fu).Methods From Apr 1993 to Fed.1997,52 cases of advanced gastric carcinoma were treated with HELF combined chemotherapy,i.e HCPT8mg/m 2/div; ;VP 16 60mg/m 2/d iv;LV 100mg/m 2/d iv and 5-FU600mg/m 2/d iv,all drugs for 5 days cycles were repeated for every 28 days.Results Four patients achieved a complete response (CR7 67%),twenty five patients had a partial response (PR48 07%),thus RR (CR+RR) was 55 76%.The RR rate was higher than ElF regimen in our control group(41 16%)( P 0 05).HELF! s longer than ELF in the mean time of servival( P 0 05).HELF combined chemotherapy produced mild and transient hemeologic toxicity,the most common toxicities were gastrointestinal reaction and alopecia.Nausea vomiting can be prevented:by 5 HT3 antireceptor drug.Conclusion HELF regimen provides new favorable and safe tretment for patients with advanced gastric carcinoma.

About this research paper

What this paper is about

Objective To study the effect of patients with advanced gstric carcinoma was systemic combined chemotherapy with ELF reginen,consisting of 10 hrdroxycmptothecine(HCPT),etoposide(Vp 16),Leucovorin(LV)and 5 fluorouracil(5 Fu).Methods From Apr 1993 to Fed.1997,52 cases of advanced gastric carcinoma were treated with HELF combined chemotherapy,i.e HCPT8mg/m 2/div; ;VP 16 60mg/m 2/d iv;LV 100mg/m 2/d iv and 5-FU600mg/m 2/d iv,all drugs for 5 days cycles were repeated for every 28 days.Results Four patients achieved a complete response (CR7 67%),twenty five patients had a partial response (PR48 07%),thus RR (CR+RR) was 55 76%.The RR rate was higher than ElF regimen in our control group(41 16%)( P 0 05).HELF! s longer than ELF in the mean time of servival( P 0 05).HELF combined chemotherapy produced mild and transient hemeologic toxicity,the most common toxicities were gastrointestinal reaction and alopecia.Nausea vomiting can be prevented:by 5 HT3 antireceptor drug.Conclusion HELF regimen provides new favorable and safe tretment for patients with advanced gastric carcinoma.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the effect of patients with advanced gstric carcinoma was systemic combined chemotherapy with ELF reginen,consisting of 10 hrdroxycmptothecine(HCPT),etoposide(Vp 16),Leucovorin(LV)and 5 fluorouracil(5 Fu).Methods From Apr 1993 to Fed.1997,52 cases of advanced gastric carcinoma were treated with HELF combined chemotherapy,i.e HCPT8mg/m 2/div; ;VP 16 60mg/m 2/d iv;LV 100mg/m 2/d iv and 5-FU600mg/m 2/d iv,all drugs for 5 days cycles were repeated for every 28 days.Results Four patients achieved a complete response (CR7 67%),twenty five patients had a partial response (PR48 07%),thus RR (CR+RR) was 55 76%.The RR rate was higher than ElF regimen in our control group(41 16%)( P 0 05).HELF! s longer than ELF in the mean time of servival( P 0 05).HELF combined chemotherapy produced mild and transient hemeologic toxicity,the most common toxicities were gastrointestinal reaction and alopecia.Nausea vomiting can be prevented:by 5 HT3 antireceptor drug.Conclusion HELF regimen provides new favorable and safe tretment for patients with advanced gastric carcinoma.

Key concepts: Vomiting, Medicine, Nausea, Regimen, Etoposide, Chemotherapy, Gastric carcinoma, Gastroenterology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
CIinical Study of HELF Combined Chemotherapy for PatientsWith Advanced Gastric Carcinoma — Research Paper | ScholarLens